✦ LIBER ✦

Tubular Toxicity in Sirolimus- and Cyclosporine-Based Transplant Immunosuppression Strategies: An Ancillary Study From a Randomized Controlled Trial

✍ Scribed by Stefan Franz; Axel Regeniter; Helmut Hopfer; Michael Mihatsch; Michael Dickenmann

Book ID: 114469424
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 563 KB
Volume: 55
Category: Article
ISSN: 0272-6386
DOI: 10.1053/j.ajkd.2009.09.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized controlled trial of late co

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin

Induction With and Without Antithymocyte

Induction With and Without Antithymocyte Globulin Combined With Cyclosporine/Tacrolimus-Based Immunosuppression in Renal Transplantation: A Meta-analysis of Randomized Controlled Trials

✍ J.H. Tian; X. Wang; K.H. Yang; A.P. Liu; X.F. Luo; J. Zhang 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 884 KB

Switch to a Sirolimus-Based Immunosuppre

Switch to a Sirolimus-Based Immunosuppression in Long-Term Renal Transplant Recipients: Reduced Rate of (Pre-)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor-Blinded, Controlled Clinical Trial

✍ R. Salgo; J. Gossmann; H. Schöfer; H. G. Kachel; J. Kuck; H. Geiger; R. Kaufmann 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB